Author

Yingjie Guo

Observed names: Y Guo, Y. Guo, Ying-Jie Guo, Yubin Ge

Institutions: Guangdong Medical College, Jilin University, Zhengzhou University, Henan Provincial People's Hospital, Arc Research Institute

Observed institutions: Guangdong Medical College, Wayne State University, Jilin University, Chinese Academy of Sciences, Zhengzhou University, Shanghai Institute of Materia Medica, Henan Provincial People's Hospital, Chinese People's Liberation Army, Arc Research Institute, State Key Laboratory of Inorganic Synthesis and Preparative Chemistry

ORCID: 0009-0004-2529-4305

Observed ORCID: 0009-0004-2529-4305

OpenAlex ID: A5113540769

Effects of UGT1A6, UGT2B7, and CYP2C9 Genotypes on Plasma Concentrations of Valproic Acid in Chinese Children with Epilepsy

2012 · Yingjie Guo, Cheng Hu, et al. · Drug Metabolism and Pharmacokinetics · 90

Identification of a novel variant CYP2C9 allele in Chinese

2004 · Dayong Si, Yingjie Guo, et al. · Pharmacogenetics · 90

Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells

2013 · Zhixin Qiao, Suping Ren, et al. · Biochemical and Biophysical Research Communications · 75

Role of Cyp2c9 and Its Variants (cyp2c9*3 and Cyp2c9*13) in the Metabolism of Lornoxicam in Humans

2005 · Yingjie Guo, Yifan Zhang, et al. · Drug Metabolism and Disposition · 64

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects

2007 · Yifan Zhang, Dayong Si, et al. · British Journal of Clinical Pharmacology · 63

PDF

Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy

2011 · Hongmei Meng, Guimei Guo, et al. · Epilepsy & Behavior · 59

Halloysite Nanotubes, a Multifunctional Nanovehicle for Anticancer Drug Delivery

2012 · Mingyi Guo, Aifei Wang, et al. · Chinese Journal of Chemistry · 54

Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype

2004 · Yifan Zhang, Dafang Zhong, et al. · British Journal of Clinical Pharmacology · 51

PDF

Class I and Class II Histone Deacetylases Are Potential Therapeutic Targets for Treating Pancreatic Cancer

2012 · Guan Wang, Jing He, et al. · PLoS ONE · 46

PDF

Catalytic activities of human cytochrome P450 2C9*1, 2C9*3 and 2C9*13

2005 · Y. Guo, Y. Wang, et al. · Xenobiotica · 44

Cucurbitacin B suppresses proliferation of pancreatic cancer cells by ceRNA: Effect of miR‐146b‐5p and lncRNA‐AFAP1‐AS1

2018 · Jingkai Zhou, Mei Liu, et al. · Journal of Cellular Physiology · 40

Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, STAT3 and ERK signaling

2017 · Jingkai Zhou, Tiangang Zhao, et al. · Oncotarget · 38

PDF

Sini Decoction Ameliorates Colorectal Cancer and Modulates the Composition of Gut Microbiota in Mice

2021 · Yishan Wang, Xiaodi Zhang, et al. · Frontiers in Pharmacology · 37

PDF

The novel dipeptide Tyr-Ala (TA) significantly enhances the lifespan and healthspan of Caenorhabditis elegans

2016 · Z. Zhang, Y. Zhao, et al. · Food & Function · 36

Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy

2015 · Qiuning Wang, Min Liang, et al. · Drug Metabolism and Pharmacokinetics · 34

Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro

2020 · Linfeng Ma, Yani Wang, et al. · Toxicology · 32

Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy

2013 · Wenting Yun, Feng Zhang, et al. · Epilepsy Research · 30

On the human CYP2C9*13 variant activity reduction: a molecular dynamics simulation and docking study

2006 · Y.-H. Zhou, Q.-C. Zheng, et al. · Biochimie · 30

Clinical and histopathological features of familial amyloidotic polyneuropathy with transthyretin Val30Ala in a Chinese family

2011 · Jing-Yao Liu, Ying-Jie Guo, et al. · Journal of the Neurological Sciences · 28

Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers

2009 · Q. Li, R. Wang, et al. · Journal of Clinical Pharmacy and Therapeutics · 25

PDF

Identification of an orally available compound with potent and broad FLT3 inhibition activity

2015 · Y Chen, Y Guo, et al. · Oncogene · 24

CHK1 inhibition sensitizes pancreatic cancer cells to gemcitabine via promoting CDK-dependent DNA damage and ribonucleotide reductase downregulation

2017 · Min Liang, Tiangang Zhao, et al. · Oncology Reports · 20

PDF

The impact of V30A mutation on transthyretin protein structural stability and cytotoxicity against neuroblastoma cells

2013 · Feng Zhang, Cheng Hu, et al. · Archives of Biochemistry and Biophysics · 20

Catalase C-262T Polymorphism Is a Risk Factor for Valproic Acid–Induced Abnormal Liver Function in Chinese Patients With Epilepsy

2018 · Linfeng Ma, Yue Pan, et al. · Therapeutic Drug Monitoring · 16

Probiotics attenuate valproate-induced liver steatosis and oxidative stress in mice

2023 · Wenfang Song, Xinrui Yan, et al. · PLoS ONE · 15

PDF

Works count: 40

Citation count: 1,132

H-index: 21

I10-index: 27